Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 249

Similar articles for PubMed (Select 10092564)

2.

Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.

Critchley J, Liu J, Zhao D, Wei W, Capewell S.

Circulation. 2004 Sep 7;110(10):1236-44. Epub 2004 Aug 30.

3.

Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993.

Capewell S, Beaglehole R, Seddon M, McMurray J.

Circulation. 2000 Sep 26;102(13):1511-6.

5.

Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?

Critchley JA, Capewell S, Unal B.

J Clin Epidemiol. 2003 Jun;56(6):583-90.

PMID:
12873654
6.

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

Unal B, Critchley JA, Capewell S.

Circulation. 2004 Mar 9;109(9):1101-7. Epub 2004 Mar 1.

7.

Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.

Fidan D, Unal B, Critchley J, Capewell S.

QJM. 2007 May;100(5):277-89. Epub 2007 Apr 21.

8.

Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study.

Bandosz P, O'Flaherty M, Drygas W, Rutkowski M, Koziarek J, Wyrzykowski B, Bennett K, Zdrojewski T, Capewell S.

BMJ. 2012 Jan 25;344:d8136. doi: 10.1136/bmj.d8136.

9.

Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data.

Hotchkiss JW, Davies CA, Dundas R, Hawkins N, Jhund PS, Scholes S, Bajekal M, O'Flaherty M, Critchley J, Leyland AH, Capewell S.

BMJ. 2014 Feb 6;348:g1088. doi: 10.1136/bmj.g1088.

10.

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.

Yudkin JS.

BMJ. 1993 May 15;306(6888):1313-8. Erratum in: BMJ 1993 Jul;307(6896):116. BMJ 1993 Jun 26;306(6894):1739.

11.

The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.

Kabir Z, Bennett K, Shelley E, Unal B, Critchley J, Feely J, Capewell S.

QJM. 2006 Aug;99(8):523-30. Epub 2006 Jul 22.

12.

Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements?

Taylor RS, Unal B, Critchley JA, Capewell S.

Eur J Cardiovasc Prev Rehabil. 2006 Jun;13(3):369-74.

PMID:
16926666
13.

Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland.

Kabir Z, Bennett K, Shelley E, Unal B, Critchley J, Feely J, Capewell S.

Eur J Public Health. 2007 Apr;17(2):193-8. Epub 2006 Jun 23.

14.

Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.

Kabir Z, Bennett K, Shelley E, Unal B, Critchley JA, Capewell S.

BMC Public Health. 2007 Jun 21;7:117.

16.

Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997.

Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S.

Am J Epidemiol. 2005 Oct 15;162(8):764-73. Epub 2005 Sep 8.

17.

Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009.

Saidi O, Ben Mansour N, O'Flaherty M, Capewell S, Critchley JA, Ben Romdhane H.

PLoS One. 2013 May 3;8(5):e63202. doi: 10.1371/journal.pone.0063202. Print 2013.

18.

Increasing the impact of cardiological treatments. How best to reduce deaths.

Capewell S, Pell JP, Morrison C, McMurray J.

Eur Heart J. 1999 Oct;20(19):1386-92.

19.

Can small changes in cardiovascular risk factors predict large future reductions in coronary heart disease mortality in Ireland?

Kabir Z, Bennett K, Critchley JA, Capewell S.

Eur J Epidemiol. 2007;22(2):83-9. Epub 2007 Feb 21.

PMID:
17318337
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk